Enrollment Begins in ACTIVATE I Study of Alucent NVS Vessel Restoration System
May 27, 2020—Alucent Biomedical Inc. announced that it has enrolled the first two patients in ACTIVATE I, a phase 1 clinical trial to evaluate the safety and efficacy of its Natural Vascular Scaffolding (NVS) technology for the treatment of peripheral artery disease (PAD) of the lower extremities.
Micro Medical Solutions Begins Pivotal STAND Trial of MicroStent to Treat BTK Arterial Disease
May 12, 2020—Micro Medical Solutions (MMS) announced the first implantation of the company’s MicroStent vascular stent in STAND, the randomized, multicenter pivotal clinical study to support FDA approval of the device to treat arterial disease below the knee.
Getinge Introduces Larger-Diameter Advanta V12 Balloon-Expandable Covered Stent to Treat Iliac Artery Disease
May 6, 2020—Getinge announced the commercial introduction of a larger-diameter Advanta V12 balloon-expandable covered stent, which expands from 12 to 16 mm, to treat iliac arterial occlusive disease.
Continuing Coverage: Paclitaxel In PAD
Adjusted and Case-Matched Analysis Evaluates Association of Paclitaxel and Mortality After Peripheral Angioplasty
May 3, 2020—An adjusted and case-matched multicenter analysis of paclitaxel and mortality after peripheral angioplasty found that when relevant risk factors were taken into account, there were no associations between paclitaxel and midterm mortality in patients with peripheral arterial occlusive disease (PAOD).
Cook Medical Will Distribute New Surmodics PTA Balloon Catheters for CLI
April 30, 2020—Cook Medical and Surmodics, Inc. announced an agreement in which Cook Medical will distribute two new Surmodics hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that can be used over 0.014- and 0.018-inch wire guides.
FDA Approves Intact Vascular's Tack Endovascular System for BTK Dissection Repair
April 14, 2020—Intact Vascular, Inc. announced FDA approval of its Tack (4-F) endovascular system for repair of postangioplasty dissections in the mid/distal popliteal, tibial, and/or peroneal below-the-knee (BTK) arteries ranging in diameter from 1.5 to 4.5 mm.
Clopidogrel With Rivaroxaban and Aspirin Shows No Added Benefit After PAD Revascularization in VOYAGER PAD Subgroup Analysis
March 29, 2020—The American College of Cardiology (ACC) announced that results from a subgroup analysis of the VOYAGER PAD trial suggest that concomitant use of clopidogrel along with a regimen of rivaroxaban and aspirin provides no added benefit after revascularization for peripheral artery disease (PAD).
VOYAGER PAD Evaluates Risk of Adverse Events With Rivaroxaban in Symptomatic PAD After Revascularization
March 28, 2020—At the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) held this year as a virtual conference, Marc P. Bonaca, MD, presented findings from the VOYAGER PAD study demonstrating that patients with symptomatic peripheral artery disease (PAD) who took rivaroxaban with aspirin after undergoing lower extremity revascularization had a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone.
SIR Issues Clinical Notification on Aerosol-Generating Procedures
March 27, 2020—The Society of Interventional Radiology (SIR) has issued a clinical notification to provide medical decision-making guidance on how to perform aerosol-generating procedures (AGP) safely in the interventional radiology suite.
American College of Surgeons Releases Clinical Guidance for Elective Surgical Case Triage During COVID-19 Outbreak
March 25, 2020—The American College of Surgeons (ACS) announced continued guidance for surgeons to curtail recommendations for elective surgical procedures to preserve the necessary resources for care of critically ill patients during the COVID-19 pandemic.
Vascular Society of Great Britain and Ireland Provides Guidelines for Managing Treatment Amid COVID-19 Pandemic
March 20, 2020—Professor Chris Imray, MD, President of the Vascular Society of Great Britain and Ireland, announced guidelines from the society to address the rapidly evolving situation regarding the COVID-19 virus as it impacts patients and the particular challenges for health care workers.
Straub Medical Launches the Rotarex S Atherectomy Device in the United States
March 12, 2020—Straub Medical LLC, the United States direct-sales subsidiary of Switzerland-based Straub Medical AG, announced the launch and first intervention performed in the United States with the Rotarex S atherectomy device for treating occlusive peripheral vascular disease in both upper and lower extremity arteries.
Prevalence and Predictors of Elevated Central Venous Pressure and Obstructive Sleep Apnea Evaluated in Patients With Lower Extremity Chronic Venous Disease
March 10, 2020—Online in Journal of Vascular Surgery: Venous & Lymphatic Disorders (JVS-VL) , Raghu Kolluri, MD, et al published findings from a study of the prevalence and predictors of elevated central venous pressure (CVP) and obstructive sleep apnea (OSA) in patients with lower extremity chronic venous disease (CVD).
Multisociety 2020 Appropriate Use Criteria Address Chronic Lower Extremity Venous Disease
March 4, 2020—The 2020 appropriate use criteria (AUC) for chronic lower extremity venous disease were published by Elna Masuda, MD, et al online in Journal of Vascular Surgery (JVS): Venous and Lymphatic Disorders.
Sponsored by Intact Vascular, Inc.
May 2020 Supplement
CLI Care in the COVID-19 Era: An Evolving Landscape
An expert panel offers their insights and strategies for providing CLI care while navigating the COVID-19 pandemic.
Moderators: Ehrin J. Armstrong, MD, MSc; and Andrew Holden, MBChB, FRANZCR, EBIR;
Panelists: Scott M. Brannan, MD; Edward D. Gifford, MD, RPVI; Bryan T. Fisher Sr, MD; Michael Lichtenberg, MD, FESC; S. Jay Mathews, MD, MS, FACC; and John H. Rundback, MD
Roundtable Discussion: COVID-19 and Lower Extremity Revascularization
How the onset of COVID-19 has affected patient selection, resources, staffing, and safety.
With Sharif Ellozy, MD; Katherine Gallagher, MD; William A. Gray, MD; Lorenzo Patrone, MD; Sreekumar Madassery, MD; Zola N’Dandu, MD, FSCAI; and Richard F. Neville, MD, FACS, DFSVS, RCPSG (Hon)
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.